VCAM-1 activation of endothelial cell protein tyrosine phosphatase 1B

Journal of Immunology

Volumn 178, Issue 6, 2007, Pages 3865-3873

  Deem, Tracy L ^b,c   Abdala Valencia, Hiam ^a,b   Cook Mills, Joan M ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; PROTEIN KINASE C ALPHA; PROTEIN TYROSINE PHOSPHATASE 1B; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME KINETICS; LYMPHOCYTE MIGRATION; MALE; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 33947193936     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.6.3865     Document Type: Article

References (50)

1. Chin, J. E., C. A. Hatfield, G. E. Winterrowd, J. R. Brashler, S. L. Vonderfecht, S. F. Fidler, R. L. Griffin, K. P. Kolbasa, R. F. Krzesicki, L. M. Sly, et al. 1997. Airway recruitment of leukocytes in mice is dependent on α4-integrins and vascular cell adhesion molecule-1. Am. J. Physiol. 272: L219-L229.
2. Baron, J. L., J. A. Madri, N. H. Ruddle, G. Hashim, and C. A. Janeway Jr. 1993. Surface expression of α 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177: 57-68.
3. Tummala, P. E., X. L. Chen, C. L. Sundell, J. B. Laursen, C. P. Hammes, R. W. Alexander, D. G. Harrison, and R. M. Medford. 1999. Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: a potential link between the renin-angiotensin system and atherosclerosis. Circulation 100: 1223-1229.
4. Wright, P. S., J. R. Cooper, K. E. Kropp, and S. J. Busch. 1999. Induction of vascular cell adhesion molecule-1 expression by IL-4 in human aortic smooth muscle cells is not associated with increased nuclear NF-κB levels. J. Cell Physiol. 180: 381-389.
5. Balogh, P., Y. Aydar, J. G. Tew, and A. K. Szakal. 2002. Appearance and phenotype of murine follicular dendritic cells expressing VCAM-1. Anat. Rec. 268: 160-168.
6. Lorenzon, P., E. Vecile, E. Nardon, E. Ferrero, J. M. Harlan, F. Tedesco, and A. Dobrina. 1998. Endothelial cell E- and P-selectin and vascular cell adhesion molecule-1 function as signaling receptors. J. Cell Biol. 142: 1381-1391.
7. Cook-Mills, J. M., and T. L. Deem. 2005. Active endothelial cell function during inflammation. J. Leukocyte Biol. 77: 487-495.
8. Etienne-Manneville, S., J. B. Manneville, P. Adamson, B. Wilbourn, J. Greenwood, and P. O. Couraud. 2000. ICAM-1-coupled cytoskeletal rearrangements and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines. J. Immunol. 165: 3375-3383.
9. Matheny, H. E., T. L. Deem, and J. M. Cook-Mills. 2000. Lymphocyte migration through monolayers of endothelial cell lines involves VCAM-1 signaling via endothelial cell NADPH oxidase. J. Immunol. 164: 6550-6559.
10. van Wetering, S., N. van den Berk, J. D. van Buul, F. P. J. Mul, I. Lommerse, R. Mous, J.-P. ten Klooster, J.-J. Zwaginga, and P. L. Hordijk. 2003. VCAM-1-mediated Rac signaling controls endothelial cell-cell contacts and leukocyte transmigration. Am. J. Physiol. 285: C343-C352.
11. Gurtner, G. C., V. Davis, H. Li, M. J. McCoy, A. Sharpe, and M. I. Cybulsky. 1995. Targeted disruption of the murine VCAM1 gene: essential role of VCAM-1 in chorioallantoic fusion and placentation. Genes Dev. 9: 1-14.
12. Tudor, K. S. R. S., K. L. Hess, and J. M. Cook-Mills. 2001. Cytokines modulate endothelial cell intracellular signal transduction required for VCAM-1-dependent lymphocyte transendothelial migration. Cytokine 15: 196-211.
13. Deem, T. L., and J. M. Cook-Mills. 2004. Vascular cell adhesion molecule-1 (VCAM-1) activation of endothelial cell matrix metalloproteinases: role of reactive oxygen species. Blood 104: 2385-2393.
14. Abdala-Valencia, H., and J. M. Cook-Mills. 2006. Vascular cell adhesion molecule (VCAM-1) signals activate endothelial cell protein kinase Ca via oxidation. J. Immunol. 177: 6379-6387.
15. Thannickal, V. J., and B. L. Fanburg. 2000. Reactive oxygen species in cell signaling. Am. J. Physiol. 279: L1005-L1028.
16. Forman, H. J., and M. Torres. 2002. Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am. J. Respir. Crit. Care Med. 166: S4-S8.
17. Sommer, D., S. Coleman, S. A. Swanson, and P. M. Stemmer. 2002. Differential susceptibilities of serine/threonine phosphatases to oxidative and nitrosative stress. Arch. Biochem. Biophys. 404: 271-278.
18. Gabel, S., J. Benefield, J. Meisinger, G. J. Petruzzelli, and M. Young. 1999. Protein phosphatases 1 and 2A maintain endothelial cells in a resting state, limiting the motility that is needed for the morphogenic process of angiogenesis. Otolaryngol. Head Neck Surg. 121: 463-468.
19. Hosoya, N., M. Mitsui, F. Yazama, H. Ishihara, H. Ozaki, H. Karaki, D. J. Hartshorne, and H. Mohri. 1993. Changes in the cytoskeletal structure of cultured smooth muscle cells induced by calyculin-A. J. Cell Sci. 105: 883-890.
20. Dadke, S., and J. Chernoff. 2003. Protein-tyrosine phosphatase 1B mediates the effects of insulin on the actin cytoskeleton in immortalized fibroblasts. J. Biol. Chem. 278: 40607-40611.
21. Liu, F., M. A. Sells, and J. Chernoff. 1998. Protein tyrosine phosphatase 1B negatively regulates integrin signaling. Curr. Biol. 8: 173-176.
22. Brautigan, D. L., and F. M. Pinault. 1993. Serine phosphorylation of protein tyrosine phosphatase (PTP1B) in HeLa cells in response to analogues of cAMP or diacylglycerol plus okadaic acid. Mol. Cell Biochem. 127-128: 121-129.
23. Flint, A. J., M. F. Gebbink, B. R. Franza, Jr., D. E. Hill, and N. K. Tonks. 1993. Multi-site phosphorylation of the protein tyrosine phosphatase, PTP1B: identification of cell cycle regulated and phorbol ester stimulated sites of phosphorylation. EMBO J. 12: 1937-1946.
24. Tudor, K.-S., T. L. Deem, and J. M. Cook-Mills. 2000. Novel α4-integrin ligands on an endothelial cell line. Biochem. Cell Biol. 78: 99-113.
25. Qureshi, M. H., J. Cook-Mills, D. E. Doherty, and B. A. Garvy. 2003. TNF-α-dependent ICAM-1- and VCAM-1-mediated inflammatory responses are delayed in neonatal mice infected with Pneumocystis carinii. J. Immunol. 171: 4700-4707.
26. Cook-Mills, J. M., J. S. Gallagher, and T. L. Feldbush. 1996. Isolation and characterization of high endothelial cell lines derived from mouse lymph nodes. In Vitro Cell Dev. Biol. Anim. 32: 167-177.
27. Cook-Mills, J. M., J. D. Johnson, T. L. Deem, A. Ochi, L. Wang, and Y. Zheng. 2004. Calcium mobilization and Rac1 activation are required for VCAM-1 (vascular cell adhesion molecule-1) stimulation of NADPH oxidase activity. Biochem. J. 378: 539-547.
28. St-Denis, A., F. Chano, P. Tremblay, Y. St-Pierre, and A. Descoteaux. 1998. Protein kinase C-α modulates lipopolysaccharide-induced functions in a murine macrophage cell line. J. Biol. Chem. 273: 32787-32792.
29. Fialkow, L., C. K. Chan, and G. P. Downey. 1997. Inhibition of CD45 during neutrophil activation. J. Immunol. 158: 5409-5417.
30. Burridge, K., and A. Nelson. 1995. An in-gel assay for protein tyrosine phosphatase activity: detection of widespread distribution in cells and tissues. Anal. Biochem. 232: 56-64.
31. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
32. Chen, Y.-H., Q. Lu, D. A. Goodenough, and B. Jeansonne. 2002. Nonreceptor tyrosine kinase c-Yes interacts with occludin during tight junction formation in canine kidney epithelial cells. Mol. Biol. Cell 13: 1227-1237.
33. Lawrence, M. B., L. V. McIntire, and S. G. Eskin. 1987. Effect of flow on polymorphonuclear leukocyte/endothelial cell adhesion. Blood 70: 1284-1290.
34. Nobis, U., A. R. Pries, G. R. Cokelet, and P. Gaehtgens. 1985. Radial distribution of white cells during blood flow in small tubes. Microvasc. Res. 29: 295-304.
35. Smith, M. L., D. S. Long, E. R. Damiano, and K. Ley. 2003. Near-wall micro-PIV reveals a hydrodynamically relevant endothelial surface layer in venules in vivo. Biophys. J. 85: 637-645.
36. Lipowsky, H. H. 2005. Microvascular rheology and hemodynamics. Microcirculation 12: 5-15.
37. Ager, A., and S. Mistry. 1988. Interaction between lymphocytes and cultured high endothelial cells: an in vitro model of lymphocyte migration across high endothelial venule endothelium. Eur. J. Immunol. 18: 1265-1274.
38. Alonso, A., J. Sasin, N. Bottini, I. Friedberg, I. Friedberg, A. Osterman, A. Godzik, T. Hunter, J. Dixon, and T. Mustelin. 2004. Protein tyrosine phosphatases in the human genome. Cell 117: 699-711.
39. Moran, E. J., S. Sarshar, J. F. Cargill, M. M. Shahbaz, A. Lio, A. M. M. Mjalli, and R. W. Arstrong. 1995. Radio frequency tag encoded combinatorial library method for the discovery of tripeptide-subsituted cinnamic acid inhibitors of the protein tyrosine phosphatase PTP1B. J. Am. Chem. Soc. 117: 10787-10788.
40. Mathai, J. C., and V. Sitaramam. 1994. Stretch sensitivity of transmembrane mobility of hydrogen peroxide through voids in the bilayer: role of cardiolipin. J. Biol. Chem. 269: 17784-17793.
41. Hansen, S. K., M. T. Cancilla, T. P. Shiau, J. Kung, T. Chen, and D. A. Erlanson. 2005. Allosteric inhibition of PTP1B activity by selective modification of a non-active site cysteine residue. Biochemistry 44: 7704-7712.
42. Martiny-Baron, G., M. G. Kazanietz, H. Mischak, P. M. Blumberg, G. Kochs, H. Hug, D. Marme, and C. Schachtele. 1993. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J. Biol. Chem. 268: 9194-9197.
43. + channels in human glomerular mesangial cells. Am. J. Physiol. 283: C1390-C1398.
44. Ezumi, Y., H. Takayama, and M. Okuma. 1995. Differential regulation of protein-tyrosine phosphatases by integrin α IIb β 3 through cytoskeletal reorganization and tyrosine phosphorylation in human platelets. J. Biol. Chem. 270: 11927-11934.
45. Groen, A., S. Lemeer, T. van der Wijk, J. Overvoorue, A. J. R. Heck, A. Ostman, D. Barford, M. Slijper, and J. den Hertog. 2005. Differential oxidation of protein-tyrosine phosphatases. J. Biol. Chem. 280: 10298-10304.
46. Keshavan, P., T. L. Deem, S. J. Schwemberger, G. F. Babcock, J. M. Cook-Mills, and S. D. Zucker. 2005. Unconjugated bilirubin inhibits VCAM-1-mediated transendothelial leukocyte migration. J. Immunol. 174: 3709-3718.
47. Cree, B. 2006. Emerging monoclonal antibody therapies for multiple sclerosis. Neurologist 12: 171-178.
48. Bennett, J. L. 2006. Natalizumab and progressive multifocal leukoencephalopathy: migrating towards safe adhesion molecule therapy in multiple sclerosis. Neurol. Res. 28: 291-298.
49. Niino, M., C. Bodner, M.-L. Simard, S. Alatab, D. Gano, H. J. Kim, M. Trigueiro, D. Racicot, C. Guerette, J. P. Antel, et al. 2006. Natalizumab effects on immune cell responses in multiple sclerosis. Ann. Neurol. 59:748-754.
50. Lanzarotto, F., M. Carpani, R. Chaudhary, and S. Ghosh. 2006. Novel treatment options for inflammatory bowel disease targeting α4 integrin. Drugs 66: 1179-1189.